• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经影像学标志物和生物标志物在脑小血管病中的作用及其与认知功能的关联。

Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function.

作者信息

Song Xiaoqian, Jin Chenyang, Luan Moxin, Zheng Xueping

机构信息

The Affiliated Hospital of Qingdao University, Qingdao, China.

Qingdao Medical College, Qingdao University, Qingdao, China.

出版信息

Front Neurol. 2025 May 1;16:1483842. doi: 10.3389/fneur.2025.1483842. eCollection 2025.

DOI:10.3389/fneur.2025.1483842
PMID:40376151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12078144/
Abstract

Cerebral small vessel disease (CSVD) is an intracranial vascular disorder caused by the impairment of cerebral microvessels, with various pathological backgrounds. Currently, a clear and definitive set of diagnostic criteria for CSVD continues to be elusive, and its diagnosis relies primarily on medical history, clinical presentation, brain imaging features, and genetic detection. In clinical practice, no single biomarker was identified. Previous studies have delved into various biomarkers in CSVD and their relationships with cognitive functions, yielding promising candidates. However, drawing a unified and conclusive consensus poses a challenge due to the inherent heterogeneity in research. Therefore, we reviewed the current progression of CSVD biomarkers and their relationship with cognitive functions, mainly including neuroimaging markers and biomarkers related to cerebrospinal fluid (CSF), as well as blood to assist clinicians in diagnosis.

摘要

脑小血管病(CSVD)是一种由脑微血管损伤引起的颅内血管疾病,具有多种病理背景。目前,一套明确、确切的CSVD诊断标准仍难以确定,其诊断主要依赖于病史、临床表现、脑成像特征和基因检测。在临床实践中,尚未发现单一的生物标志物。先前的研究已深入探讨了CSVD中的各种生物标志物及其与认知功能的关系,产生了有前景的候选物。然而,由于研究中固有的异质性,达成统一且确凿的共识面临挑战。因此,我们综述了CSVD生物标志物的当前进展及其与认知功能的关系,主要包括神经影像标志物以及与脑脊液(CSF)相关的生物标志物,还有血液标志物,以协助临床医生进行诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9b5/12078144/a773be41204c/fneur-16-1483842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9b5/12078144/a773be41204c/fneur-16-1483842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9b5/12078144/a773be41204c/fneur-16-1483842-g001.jpg

相似文献

1
Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function.神经影像学标志物和生物标志物在脑小血管病中的作用及其与认知功能的关联。
Front Neurol. 2025 May 1;16:1483842. doi: 10.3389/fneur.2025.1483842. eCollection 2025.
2
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
3
Biomarkers involved in the pathogenesis of cerebral small-vessel disease.参与脑小血管病发病机制的生物标志物。
Front Neurol. 2022 Sep 1;13:969185. doi: 10.3389/fneur.2022.969185. eCollection 2022.
4
Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment.脑小血管病改变了神经血管单元对涉及血管性认知障碍的微循环完整性的调节。
Neurobiol Dis. 2022 Aug;170:105750. doi: 10.1016/j.nbd.2022.105750. Epub 2022 May 14.
5
Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease.脑小血管病的血浆生物标志物与影像学特征的相关性
Brain Sci. 2024 Mar 12;14(3):269. doi: 10.3390/brainsci14030269.
6
Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis.伴有认知障碍的脑小血管病的潜在生物标志物:一项系统评价和荟萃分析
Front Aging Neurosci. 2025 Jan 7;16:1475571. doi: 10.3389/fnagi.2024.1475571. eCollection 2024.
7
Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease.基于光学相干断层扫描的脑小血管病视网膜血管病变评估
Neurol Res Pract. 2020 May 15;2:13. doi: 10.1186/s42466-020-00062-4. eCollection 2020.
8
Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes.同型半胱氨酸与脑小血管病的发生有关:来自神经影像学和认知结果的回顾性分析。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105393. doi: 10.1016/j.jstrokecerebrovasdis.2020.105393. Epub 2020 Oct 29.
9
Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.可溶性触发受体表达于髓样细胞2、阿尔茨海默病病理学与脑小血管病进展风险:一项纵向研究
J Alzheimers Dis. 2023;92(1):311-322. doi: 10.3233/JAD-220731.
10
Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.脑淀粉样血管病中去骨架化平均扩散率的峰宽:空间特征、认知及神经影像学关联
Front Neurosci. 2022 Nov 11;16:1051038. doi: 10.3389/fnins.2022.1051038. eCollection 2022.

本文引用的文献

1
Neurofilaments as biomarkers in neurological disorders - towards clinical application.神经丝作为神经紊乱的生物标志物——迈向临床应用。
Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12.
2
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.NFL 和 GFAP 在(前)症状性 RVCL-S 携带者中的表达:一种单基因脑小血管疾病。
J Neurol. 2024 Jul;271(7):4138-4145. doi: 10.1007/s00415-024-12292-6. Epub 2024 Apr 6.
3
Association between C677T polymorphism and cognitive impairment in patients with cerebral small vessel disease: a cross-sectional study.
脑小血管病患者C677T基因多态性与认知障碍的相关性:一项横断面研究
Front Aging Neurosci. 2024 Feb 19;16:1334011. doi: 10.3389/fnagi.2024.1334011. eCollection 2024.
4
Blood-based biomarkers of cerebral small vessel disease.脑小血管病的基于血液的生物标志物。
Ageing Res Rev. 2024 Mar;95:102247. doi: 10.1016/j.arr.2024.102247. Epub 2024 Feb 27.
5
CADASIL: A NOTCH3-associated cerebral small vessel disease.伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病:一种与NOTCH3相关的脑小血管病。
J Adv Res. 2024 Dec;66:223-235. doi: 10.1016/j.jare.2024.01.001. Epub 2024 Jan 2.
6
Enlarged perivascular spaces and plasma Aβ42/Aβ40 ratio in older adults without dementia.无痴呆的老年人中血管周围间隙扩大和血浆 Aβ42/Aβ40 比值。
Neurobiol Aging. 2023 Aug;128:43-48. doi: 10.1016/j.neurobiolaging.2023.04.004. Epub 2023 Apr 14.
7
Cerebral Small Vessel Disease Progression and the Risk of Dementia: A 14-Year Follow-Up Study.脑小血管病进展与痴呆风险:一项 14 年随访研究。
Am J Psychiatry. 2023 Jul 1;180(7):508-518. doi: 10.1176/appi.ajp.20220380. Epub 2023 Apr 19.
8
YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease.YKL-40作为一种与脑小血管病患者白质损伤和认知障碍相关的新型生物标志物。
Brain Res. 2023 May 15;1807:148318. doi: 10.1016/j.brainres.2023.148318. Epub 2023 Mar 8.
9
Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease.血浆寡聚淀粉样蛋白β-42 水平升高与脑小血管病认知障碍有关。
Biosensors (Basel). 2023 Jan 7;13(1):110. doi: 10.3390/bios13010110.
10
Effects of Carotid Artery Stiffness on Cerebral Small-Vessel Disease and Cognition.颈动脉僵硬度对脑小血管病和认知功能的影响。
J Am Heart Assoc. 2022 Dec 6;11(23):e027295. doi: 10.1161/JAHA.122.027295. Epub 2022 Nov 29.